A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.

The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...

DUBLIN, May 13, 2025 - Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the appointment of Susan Rodriguez ...

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced executive leadership changes as part of its succession ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...

Amid a slew of recent shake-ups at the FDA—including the agency’s reduction in force and high-profile leadership exits—the regulator is ushering in "radical" changes to how it signs off on ...

Robert F. Kennedy Jr. goes to Capitol Hill to promote and defend his massive overhaul of HHS, and President Trump's plans to ...

changes in FDA leadership; and (3) plans to reorganize the Agency and reduce its workforce. On March 25, 2025, Martin "Marty" Makary was confirmed by the Senate to be the 27th Commissioner of Food ...

Now is the time for the biotechnology sector to ask for big changes to the FDA, NIH, reimbursement, intellectual property and ...

Health and Human Services employees were told in March to remove 'nicknames' from email systems and signatures to comply with ...

Regulatory environment tightening with FDA leadership change, adding uncertainty to Sarepta's near-term outlook and potential delays in approvals. However, the stock has underperformed since then ...